Enter your information to understand your C-Peptide levels.

The History of C-Peptide

C-peptide's story is inseparable from one of the most important discoveries in all of diabetes research: in 1967, American biochemist Donald Steiner at the University of Chicago discovered that insulin isn't actually produced directly by the pancreas in its final, biologically active form, as scientists had long simply assumed without ever seriously questioning it at all closely. Instead, Steiner found that the body first manufactures a single, longer precursor molecule called proinsulin, which is then precisely cut into two separate pieces — the insulin hormone itself, and a leftover connecting fragment he named "C-peptide," short for connecting peptide, describing its original position bridging the two chains of the larger proinsulin molecule before specialized enzymes cleaved it apart inside the pancreas cells themselves.

What C-Peptide Actually Is

Because the pancreas releases one molecule of C-peptide for every single molecule of natural insulin it produces, measuring C-peptide gives doctors a reliable window into exactly how much insulin a person's own body is genuinely manufacturing on its own, entirely independent of any injected medication a patient might be taking regularly. This is especially useful in patients who inject insulin as medication for diabetes, since injected insulin contains no C-peptide at all, allowing doctors to measure a patient's natural, endogenous insulin production even while external insulin is actively circulating in their bloodstream at the very same time. Low C-peptide often points toward type 1 diabetes, where the pancreas has stopped producing insulin altogether, while normal or high C-peptide alongside high blood sugar more often suggests type 2 diabetes, where the pancreas still functions but the body no longer responds properly to its own insulin signal as it should under normal, healthy conditions overall.

How C-Peptide Is Measured

C-peptide is measured using immunoassay techniques, in which laboratory antibodies engineered to bind specifically to C-peptide's unique molecular shape react precisely with the substance present in a blood sample being carefully tested in the lab. Modern testing platforms typically use chemiluminescent or electrochemiluminescent methods, in which this antibody binding triggers a light-emitting chemical reaction whose intensity is precisely measured by automated laboratory equipment in a matter of just a few minutes, having largely replaced the older radioactive-tracer-based radioimmunoassay techniques originally used when the test was first developed and introduced decades ago into routine clinical practice everywhere.

Scientists Behind the Science

Donald Steiner's 1967 discovery of proinsulin and C-peptide fundamentally reshaped scientific understanding of how the body manufactures hormones in general, not just insulin specifically for regulating blood sugar levels throughout the day and night. His research established the broader biological principle that many peptide hormones are first built as larger, inactive precursor molecules that must be precisely cut into their final, active forms before they can function properly anywhere in the body at all. This concept transformed the entire field of endocrinology well beyond diabetes research alone, and Steiner's work earned him numerous major scientific honors throughout his long and distinguished career, remaining foundational to how modern medicine understands hormone production and secretion today.